Silvia Vicenzi/LinkedIn
Dec 29, 2025, 23:55
Silvia Vicenzi: From a Hormone-Centric Model to an Immune-Centric Understanding of the Disease
Silvia Vicenzi, Business Development Manager at Biocytogen, posted on LinkedIn:
“The kind of science we need more of: rigorous, human, and deeply purpose-driven. The latest Science feature on endometriosis research highlights a critical shift in the field: from a hormone-centric model to an immune-centric understanding of the disease.
Emerging data show that endometriotic lesions are shaped by:
- immune dysregulation (macrophage activation, altered NK cell function)
- chronic inflammatory signaling (IL-6, TNF-α, prostaglandins)
- aberrant tissue remodeling and angiogenesis
- immune–epithelial cross-talk driving lesion persistence
This reframes endometriosis as a complex immuno-inflammatory disorder, not just a reproductive one.
Why this matters:
- It opens the door to non-hormonal interventions that target pathways like inflammation, cytokine signaling, or immune cell recruitment.
- It supports development of diagnostic biomarkers based on immune signatures instead of invasive surgery.
- It aligns endometriosis with broader patterns seen in autoimmune-adjacent diseases.
Women’s health research is finally gaining the scientific attention it deserves — and immunology is at the center of that shift.
If you want to read the entire article here.”
Get insights from Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question